FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy

Ultragenyx has committed to provide two years of safety and efficacy data from an open-label treatment group. Credit: alicancomertpay / Shutterstock.com.



  • FDA Ultragenyx Genglycos